Skip to Content

'
Qiuling Shi, MD, PhD, MSc

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Department of Symptom Research
1515 Holcombe Boulevard
Unit Number: 1450
Houston, TX 77030
Room Number: FCT11.5076
Phone: (713) 563-1341
Fax: (713) 745-3470

Education & Training

Degree-Granting Education

2000 The Fourth Military Medical University, Xi'an, China, PHD, Epidemiology and Biostatistics
1997 The Fourth Military Medical University, Xi'an, China, MS, Epidemiology and Biostatistics
1994 West China University of Medical Science, Chengdu, China, BMed/Medical Diploma, Preventive Medicine

Postgraduate Training

9/2005-1/2007 Hawn Postdoctoral Fellowship, Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Charles Cleeland
9/2002-9/2005 Research Fellowship, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Qingyi Wei
9/2000-8/2002 Research Fellowship, Epidemiology, Natl Inst for Occupational Health & Poison Control, Chinese Cntr for Disease Control and Prevention, Beijing, China, Dr. Fengsheng He

Selected Publications

Peer-Reviewed Original Research Articles

1. Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. e-Pub 3/9/2013. NIHMSID: NIHMS454103.
2. Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer 117(12):2779-90, 6/15/2011. e-Pub 4/14/2011. PMCID: PMC3143572.
3. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 29(8):994-1000, 3/2011. e-Pub 1/2011. PMCID: PMC3068055.
4. Shi Q, Cleeland CS, Klepstad P, Miaskowski C, Pedersen NL, GeneQOL Consortium. Biological pathways and genetic variables involved in pain. Qual Life Res 19(10):1407-17, 12/2010. e-Pub 9/15/2010. PMID: 20842532.
5. Sprangers MA, Sloan JA, Barsevick A, Chauhan C, Dueck AC, Raat H, Shi Q, Van Noorden CJ. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res 19(10):1395-1403, 12/2010. PMCID: PMC2977054.
6. Shi Q, Trask PC, Wang XS, Mendoza TR, Apraku WA, Malekifar M, Cleeland CS. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage 40(2):191-9, 8/2010. e-Pub 6/25/2010. PMID: 20579835.
7. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM, Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24(6):968-74, 8/2010. e-Pub 3/29/2010. PMCID: PMC2897921.
8. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced non-small cell lung cancer. Cancer 116(1):137-45, 1/1/2010. e-Pub 10/2009. PMID: 19852033.
9. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi Q, Shinozaki G, Singh JA, Yang P, Zwinderman AH. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 12(3):301-11, 6/2009. PMID: 19456223.
10. Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current-pain ratings and pain recalled from the past week. J Pain Symptom Manage 37(2):168-74, 2/2009. e-Pub 8/3/2008. PMCID: PMC2705174.
11. Wang XS, Shi Q, Williams LA, Cleeland CS, Mobley GM, Reuben JM, Lee BN, Giralt SA. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 113(8):2102-9, 10/15/2008. PMCID: PMC2633777.
12. Shi Q, Langer G, Cohen J, Cleeland CS. People in pain: How do they seek relief? J Pain 8(8):624-36, 8/2007. e-Pub 6/22/2007. PMID: 17586099.
13. Wang L, Wei Q, Shi Q, Guo Z, Qiao Y, Spitz MR. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis 28(7):1430-6, 7/2007. e-Pub 3/6/2007. PMID: 17341660.

Abstracts

1. Shi Q, Smith T, Mendoza T, Kaw C, Cleeland CS. Symptom burden in cancer survivors: a report from the American Cancer Society's studies of cancer survivors. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - June 2, 2009. J Clin Oncol 27(15 Suppl) (#9598), 5/2009.

Book Chapters

1. Shi Q, Cleeland CS. Genetic approaches to treating and preventing symptoms in patients with cancer. In: Cancer Symptom Science: Measurement, Mechanisms, and Management. Ed(s) CS Cleeland, MJ Fisch, AJ Dunn. Cambridge University Press: Cambridge UK, 192-205, 2011.

Last updated: 7/25/2013